Private Health Insurance Offers Faster Access Than Public Plans

A recent article argues that while Israeli healthcare is world-class, accessibility is a major issue, making private health insurance a necessity rather than a luxury. The author contends that the public debate often oversimplifies the complex reality of "double insurance" between public health fund supplementary services (Shaban) and private policies, portraying it as a simple case of consumers being exploited by insurers and agents.

However, the article highlights significant limitations within the Shaban system that are often unknown to the public. Unlike private insurance, Shaban restricts patients to specific hospitals within its network, preventing doctors from referring them to facilities outside the agreement even if medically advantageous. This can lead to prolonged waits for procedures, as patients may remain on waiting lists even when openings exist at non-approved hospitals.

Furthermore, Shaban often requires approval from medical committees for various procedures, regardless of the treating physician's recommendation. This bureaucratic process can cause delays and override medical judgment, with decisions driven by financial criteria rather than patient needs. In contrast, private insurance policies typically rely on the surgeon's recommendation, bypassing these committees and accelerating the process.

The article also points out a critical technological gap: Shaban uses closed lists of approved medical devices and implants. Doctors operating under Shaban are limited to these specific items, potentially preventing patients from receiving the most advanced medical technology available. Private insurance, however, allows doctors to recommend the best-suited implants and equipment based solely on medical considerations.

Finally, the piece addresses physician compensation, noting that Shaban agreements generally offer lower remuneration than private insurance policies. This disparity, the author suggests, can inadvertently create a "second-class patient" experience for those relying solely on Shaban, as doctors may face incentives that lead to longer wait times and altered treatment dynamics. The article concludes that private insurance acts as a crucial bridge to timely and effective healthcare, especially when public options face bureaucratic hurdles and accessibility challenges.